研究概要
结果:被归类为高 NK 活性(10 pg/mL)的患者相比低活性患者,总生存期显著更好(log-rank p = 0.032)。
中文摘要
背景/目的:自然杀伤(NK)细胞是固有免疫防御的重要介质,在肝移植(LT)后的肿瘤监视中发挥关键作用。尽管如此,移植前NK细胞活性在活体供肝移植(LDLT)中的预后相关性尚未完全明确。方法:本回顾性分析纳入134例接受LDLT的成年患者。移植前通过干扰素释放试验评估NK细胞活性,并分为低活性(<10 pg/mL)或高活性(≥10 pg/mL)。对所有参与者评估总生存期(OS),而对HCC患者分析无复发生存期(RFS)。结果:与低活性患者相比,高NK活性(≥10 pg/mL)患者的总生存期显著更好(log-rank p = 0.032)。在多变量分析中,高NK活性显示出改善总生存期的强烈趋势(HR,0.52;95% CI,0.26-1.04;p = 0.063)。在HCC受者中,高NK活性与无复发生存期显著改善相关(log-rank p = 0.004)。多变量Cox回归进一步确定NK活性是肿瘤复发的独立因素(HR,0.27;95% CI,0.08-0.87;p = 0.028)。结论:移植前NK细胞活性可独立预测LDLT后的生存和复发。
展开英文摘要原文
Background/Objectives : Natural killer (NK) cells are essential mediators of innate immune defense and play a key role in tumor surveillance following liver transplantation (LT). Despite this, the prognostic relevance of pre-transplant NK cell activity in living donor LT (LDLT) has not been fully established. Methods : This retrospective analysis included 134 adult patients who underwent LDLT. NK cell activity was evaluated prior to transplantation using interferon- release assays and classified as low (<10 pg/mL) or high ( 10 pg/mL). Overall survival (OS) was assessed for all participants, whereas recurrence-free survival (RFS) was analyzed patients with HCC. Results : Patients classified as having high NK activity ( 10 pg/mL) experienced significantly better overall survival compared to those with low activity (log-rank p = 0.032). In the multivariate analysis, high NK activity showed a strong trend toward improved overall survival (HR, 0.52; 95% CI, 0.26-1.04; p = 0.063). Among recipients with HCC, high NK activity was associated with a markedly improved recurrence-free survival (log-rank p = 0.004). Multivariate Cox regression further established NK activity as an independent factor for tumor recurrence (HR, 0.27; 95% CI, 0.08-0.87; p = 0.028). Conclusions : Pre-transplant NK cell activity independently predicts both survival and recurrence following LDLT.
论文信息
- 作者
- Han ES、Choi HJ、Chun JH、Kim J、You YK
- 单位
- Department of Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.South Korea
- 期刊
- Journal of clinical medicine2026 Mar 16